Arisostatins A and B, new members of tetrocarcin class of antibiotics from Micromonospora sp. TP-A0316. II. Structure determination. 2000

Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
Biotechnology Research Center, Toyama Prefectural University, Kosugi, Japan.

Structures of arisostatins A and B were determined by spectroscopic analyses. Arisostatins were found to be new analogs of tetrocarcin A and possess an iso-butanoyldigitoxose unit instead of the acetyldigitoxose one. NMR analyses of arisostatins and tetrocarcin A led to the revision of the anomeric configurations in the tetrasaccharide moiety of tetrocarcin A.

UI MeSH Term Description Entries
D008847 Micromonospora A genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments. Micromonospora echinospora
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002236 Carbohydrate Conformation The characteristic 3-dimensional shape of a carbohydrate. Carbohydrate Linkage,Carbohydrate Conformations,Carbohydrate Linkages,Conformation, Carbohydrate,Conformations, Carbohydrate,Linkage, Carbohydrate,Linkages, Carbohydrate
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D013053 Spectrophotometry The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.

Related Publications

Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
February 2002, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
July 2001, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
September 1999, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
March 2002, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
December 1993, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
August 1990, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
December 2007, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
April 2000, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
March 2003, The Journal of antibiotics,
Y Igarashi, and K Takagi, and Y Kan, and K Fujii, and K Harada, and T Furumai, and T Oki
March 1994, The Journal of antibiotics,
Copied contents to your clipboard!